These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33414088)

  • 21. Association between single-nucleotide polymorphisms in the endothelial lipase (LIPG) gene and high-density lipoprotein cholesterol levels.
    Mank-Seymour AR; Durham KL; Thompson JF; Seymour AB; Milos PM
    Biochim Biophys Acta; 2004 Feb; 1636(1):40-6. PubMed ID: 14984737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity.
    Sich D; Saïdi Y; Giral P; Lagrost L; Egloff M; Auer C; Gautier V; Turpin G; Beucler I
    Metabolism; 1998 Aug; 47(8):965-73. PubMed ID: 9711993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-density lipoprotein-cholesterol, its subfractions, and responses to exercise training are dependent on endothelial lipase genotype.
    Halverstadt A; Phares DA; Ferrell RE; Wilund KR; Goldberg AP; Hagberg JM
    Metabolism; 2003 Nov; 52(11):1505-11. PubMed ID: 14624415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-Based Resequencing of LIPG and ZNF202 Genes in Subjects with Extreme HDL Levels.
    Razzaghi H; Santorico SA; Kamboh MI
    Front Genet; 2012; 3():89. PubMed ID: 22723803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-density lipoprotein subfractions and influence of endothelial lipase in a healthy Turkish population: a study in a land of low high-density lipoprotein cholesterol.
    Kilic H; Atalar E; Lay I; Yazihan N; Buyukcam F; Saygisunar U; Aksoy M; Gunduz H; Akdemir R
    Scand J Clin Lab Invest; 2014 Jun; 74(4):278-84. PubMed ID: 24479875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extremely elevated HDL-cholesterol levels are not associated with increased carotid intima-media thickness: data from ELSA Brasil.
    Laurinavicius AG; Santos IS; Santos RD; Bensenor IM; Conceição RD; Lotufo PA
    J Clin Lipidol; 2016; 10(4):898-904.e1. PubMed ID: 27578121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
    Hirano K; Yamashita S; Nakajima N; Arai T; Maruyama T; Yoshida Y; Ishigami M; Sakai N; Kameda-Takemura K; Matsuzawa Y
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1053-9. PubMed ID: 9194754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia.
    Inazu A; Koizumi J; Haraki T; Yagi K; Wakasugi T; Takegoshi T; Mabuchi H; Takeda R
    Hum Genet; 1993 Mar; 91(1):13-6. PubMed ID: 8454281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism.
    Ma K; Cilingiroglu M; Otvos JD; Ballantyne CM; Marian AJ; Chan L
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2748-53. PubMed ID: 12601178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of the LIPG 584C>T polymorphism and alcohol consumption on serum lipid levels.
    Liu WY; Yin RX; Zhang L; Wu DF; Htet Aung LH; Hu XJ; Cao XL; Miao L
    Alcohol; 2011 Nov; 45(7):681-7. PubMed ID: 21816559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesteryl ester transfer protein gene: two common mutations and their effect on plasma high-density lipoprotein cholesterol content.
    Akita H; Chiba H; Tsuchihashi K; Tsuji M; Kumagai M; Matsuno K; Kobayashi K
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1615-8. PubMed ID: 7989465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
    Duncan MS; Vasan RS; Xanthakis V
    J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.
    Miettinen HE; Gylling H; Tenhunen J; Virtamo J; Jauhiainen M; Huttunen JK; Kantola I; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):591-8. PubMed ID: 9555865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial Lipase Variant, T111I, Does Not Alter Inhibition by Angiopoietin-like Proteins.
    Sylvers-Davie KL; Bierstedt KC; Schnieders MJ; Davies BSJ
    bioRxiv; 2023 Aug; ():. PubMed ID: 37693454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia.
    El Khoury P; Plengpanich W; Frisdal E; Le Goff W; Khovidhunkit W; Guerin M
    Atherosclerosis; 2014 May; 234(1):193-9. PubMed ID: 24674903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase.
    Hirano K; Yamashita S; Kuga Y; Sakai N; Nozaki S; Kihara S; Arai T; Yanagi K; Takami S; Menju M
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1849-56. PubMed ID: 7583564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Postgrad Med J; 2008 Nov; 84(997):590-8. PubMed ID: 19103817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease.
    de Fost M; Langeveld M; Franssen R; Hutten BA; Groener JE; de Groot E; Mannens MM; Bikker H; Aerts JM; Kastelein JJ; Hollak CE
    Atherosclerosis; 2009 May; 204(1):267-72. PubMed ID: 18842264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.